glp-1/gip/glucagon triple agonist name LY3437943, a novel glucagon, GIP, and GLP-1 receptor for glycemic control and weight loss: From discovery to clinical proof of concept ποΈ NEW EPISODE: RetatrutideβThe Triple
Description
Mostly delivered via subcutaneous injection shot, GLP-1 agonist medications mimic this hormones role in the body
1 This article explores the emerging role of GLP-1RAs, originally developed for diabetes and obesity, in treating alcohol addiction
Millions of Americans have shed pounds with help from drugs like Wegovy and Zepbound
Burcelin R, Gourdy P, Dalle S
(See: Are compounded GLP-1 medications covered by insurance
